Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations
Haiyen E. Zhau(Cedars-Sinai Medical Center), M. Craig Hall(The University of Texas Southwestern Medical Center), Rodney Davis(The University of Texas MD Anderson Cancer Center), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Bao-Qi Chen(The University of Texas MD Anderson Cancer Center), Ninjia Zheng(The University of Texas MD Anderson Cancer Center), Xiao Li(Jiangsu Province Hospital), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Judd W. Moul(Uniformed Services University of the Health Sciences), Chinghai Kao(University of Virginia), Munekado Kojima(Kyoto University), Ming-Fu Ye(Xinqiao Hospital), J. Lynn Palmer(The University of Texas MD Anderson Cancer Center), Lian-Sheng Zhao, Leland W.K. Chung(VA Palo Alto Health Care System)
Cited by 19
Related Papers
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637